DDC Enterprise Announces First Half 2025 Earnings Conference Call for September 4, 2025

DDC Enterprise Limited (NYSE: DDC) ("DDC" or the " Company "), an Asian consumer-first company at the forefront of corporate bitcoin acquisition and treasury management, today announced it will report its financial results for the first half of 2025 on Thursday, September 4, 2025 at 8:00 AM EDT. DDC will cover the financial results for the six months ended June 30, 2025, as well as provide a business update.

DDC will release its earnings before the call at approximately 7:00 AM EDT on September 4, 2025. A copy of the earnings release will be available on the Company's Investor Relations website at ir.DDC.xyz.

Conference Call Information:

  • Date : September 4, 2025
  • Time : 8:00 AM EDT
  • Participant Call Links :

Participants wishing to join the conference call by phone should register using the Participant Call Registration link provided above. After completing the registration, the participants will receive an email with the necessary details to access the call, including the dial-in number, passcode, and PIN. To ensure a timely start, the Company encourages all callers to connect 5 minutes before the scheduled time.

A live and archived webcast of the conference call will be available on the Investors section of DDC's website at ir.DDC.xyz.

About DDC Enterprise Limited (NYSE: DDC)

DDC Enterprise Limited (NYSE: DDC) is spearheading the corporate Bitcoin treasury revolution while maintaining its foundation as a leading global Asian food platform. The Company has strategically positioned Bitcoin as a core reserve asset, executing a bold and accelerating accumulation strategy. While continuing to grow its portfolio of culinary brands, DDC is now at the vanguard of public companies integrating Bitcoin into their financial architecture.

Media & Investor Contacts

Investor Relations
Orange Group | Yujia Zhai
ddc@orangegroupadvisors.com

Press and Media
pr@ddc.xyz

News Provided by Business Wire via QuoteMedia

DDC
The Conversation (0)
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors

Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors

NUV-1511 is the first clinical candidate from the company's novel drug-drug conjugate platform Company anticipates initiating a Phase 1/2 clinical study of NUV-1511 in 1H 2024 Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by... Keep Reading...
Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update

Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update

Phase 1 monotherapy study of NUV-868 and Phase 1b study of NUV-868 in combination with olaparib or enzalutamide are ongoing Expect to submit an IND for first Drug-Drug Conjugate (DDC) clinical candidate by year end 2023 Strong balance sheet with cash, cash equivalents, and marketable securities... Keep Reading...
Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

Enrollment ongoing in the Phase 1b study of NUV-868 in combination with olaparib or enzalutamide Enrollment ongoing in the Phase 1 monotherapy study of NUV-868 Expect to submit an IND for first Drug-Drug Conjugate (DDC) clinical candidate by year end 2023 Announced formation of oncology-focused... Keep Reading...
Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board

Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board

Scientific Advisory Board members bring significant global expertise in oncology drug and clinical development Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today... Keep Reading...
Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update

Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update

Enrollment ongoing in the Phase 1b study of NUV-868 in combination with olaparib or enzalutamide Enrollment ongoing in the Phase 1 monotherapy study of NUV-868 Expect to submit an IND for first Drug-Drug Conjugate (DDC) clinical candidate by year end 2023 Strong balance sheet with cash, cash... Keep Reading...
Justin Grossbard, co-founder of CompareForexBrokers.

Managing Wealth Across Borders: Q&A with CompareForexBrokers’ Justin Grossbard

Navigating international money transfers can be costly and complex, with hidden fees and poor exchange rates often eroding returns. To shed light on how individuals and businesses can better manage these transactions, the Investing News Network sat down for a Q&A with Justin Grossbard,... Keep Reading...
Text saying "decentralized finance" with colorful digital chart backdrop.

A Guide to DeFi: Understanding Decentralized Finance

Decentralized finance (DeFi) is a revolutionary shift in the financial landscape, offering a blockchain-based system that facilitates transactions without relying on traditional intermediaries like banks or brokerages. While the DeFi sector experienced a challenging period through 2022 and early... Keep Reading...
Contactless payment with blue card on smartphone displaying €18.00.

Digital Finance Fuels Record Savings Growth in Developing Nations: World Bank

Formal saving in developing economies surged to its highest level in more than a decade in 2024, powered largely by the widespread use of mobile phones and digital financial tools, the World Bank said in its new Global Findex 2025 report.For the first time, 40 percent of adults in low- and... Keep Reading...
Blue cubes with illuminated edges and symbols, arranged in a geometric pattern.

Fintech Firm Velocity Raises US$10 Million for Enterprise Stablecoin Infrastructure

In what is believed to be the largest European pre-seed funding round of the year, UK fintech startup Velocity has emerged with US$10 million in early backing to develop a stablecoin infrastructure platform. The initiative is aimed squarely at large enterprises grappling with outdated... Keep Reading...
Equity Story Group Limited

Strategic Investor Acquires 11.6% of Equity Story and New Director Appointment

The Board of Equity Story Group Ltd (ASX: EǪS) ("Equity Story" or "the Company") is pleased to announce that Capital Haus Pty Ltd has acquired an 11.6% strategic stake in the Company at 2.6 cents per share, aligning with the last traded price on the ASX. Capital Haus, a wealth management firm... Keep Reading...
Man holding iPad with fintech imagery above.

Top 5 NASDAQ Fintech Stocks (Updated January 2025)

Fintech, or financial technology, has become an integral part of everyday life, and many US fintech stocks are seeing success.Firms like Boston Consulting Group and Silicon Valley Bank are projecting growth in the market, and since the fintech umbrella covers such a wide range of companies,... Keep Reading...

Latest Press Releases

Related News